Yadav G, Narayan Pratihary B, Jain G, Paswan A, Mishra L
J Anaesthesiol Clin Pharmacol. 2013; 29(1):61-5.
PMID: 23493482
PMC: 3590545.
DOI: 10.4103/0970-9185.105800.
Sankar R
CNS Drugs. 2011; 26(3):229-44.
PMID: 22145708
DOI: 10.2165/11599020-000000000-00000.
June H, Murphy J, Lumeng L, Li T
Psychopharmacology (Berl). 1994; 115(3):325-31.
PMID: 7871072
DOI: 10.1007/BF02245073.
Scholfield C
Naunyn Schmiedebergs Arch Pharmacol. 1982; 318(4):274-80.
PMID: 7078662
DOI: 10.1007/BF00501165.
Hoehn-Saric R
Psychopharmacology (Berl). 1983; 80(4):338-41.
PMID: 6414002
DOI: 10.1007/BF00432116.
Interaction of calcium channel blockers with non-neuronal benzodiazepine binding sites.
Cantor E, Kenessey A, SEMENUK G, Spector S
Proc Natl Acad Sci U S A. 1984; 81(5):1549-52.
PMID: 6324202
PMC: 344874.
DOI: 10.1073/pnas.81.5.1549.
Heterogeneity in the physicochemical properties of deoxycholate-solubilized benzodiazepine receptors from calf cerebral cortex.
Sherman-Gold R, Dudai Y
Neurochem Res. 1983; 8(7):853-64.
PMID: 6312347
DOI: 10.1007/BF00964546.
Diethylpyrocarbonate modification of benzodiazepine receptors from calf cerebral cortex.
Sherman-Gold R, Dudai Y
Neurochem Res. 1983; 8(2):259-67.
PMID: 6304551
DOI: 10.1007/BF00963925.
Super-high-affinity binding site for [3H]diazepam in the presence of Co2+, Ni2+, Cu2+, or Zn2+.
Mizuno S, Ogawa N, Mori A
Neurochem Res. 1982; 7(12):1487-93.
PMID: 6302538
DOI: 10.1007/BF00965091.
Brain levels of tofizopam in the rat and relationship with benzodiazepine receptors.
Mennini T, Abbiati A, Caccia S, Cotecchia S, Gomez A, Garattini S
Naunyn Schmiedebergs Arch Pharmacol. 1982; 321(2):112-5.
PMID: 6296700
DOI: 10.1007/BF00518477.
The effects of benzodiazepine and non-benzodiazepine anxiolytics on locus coeruleus unit activity.
Sanghera M, German D
J Neural Transm. 1983; 57(4):267-79.
PMID: 6140300
DOI: 10.1007/BF01248998.
Profile of acute tolerance to three sedative anxiolytics.
Ellinwood Jr E, Linnoila M, Easler M, Molter D
Psychopharmacology (Berl). 1983; 79(2-3):137-41.
PMID: 6133300
DOI: 10.1007/BF00427800.
The GABA hypothesis of the pathogenesis of hepatic encephalopathy: current status.
Jones E, Schafer D, Ferenci P, Pappas S
Yale J Biol Med. 1984; 57(3):301-16.
PMID: 6093394
PMC: 2589853.
Recent studies on the brain benzodiazepine receptor.
Waddington J
Ir J Med Sci. 1984; 153(8):263-7.
PMID: 6092296
DOI: 10.1007/BF02939898.
Protection against the lethal effects of pentobarbital in mice by a benzodiazepine receptor inverse agonist, 6,7-dimethoxy-4-ethyl-3-carbomethoxy-beta-carboline.
Havoundjian H, Reed G, Paul S, Skolnick P
J Clin Invest. 1987; 79(2):473-7.
PMID: 3027125
PMC: 424105.
DOI: 10.1172/JCI112836.
Midazolam cue in rats: effects of Ro 15-1788 and picrotoxin.
Stolerman I, Garcha H, Rose I
Psychopharmacology (Berl). 1986; 89(2):183-8.
PMID: 3014590
DOI: 10.1007/BF00310626.
Does the excitatory amino acid receptor antagonist 2-APH exhibit anxiolytic activity?.
Stephens D, Meldrum B, WEIDMANN R, Schneider C, Grutzner M
Psychopharmacology (Berl). 1986; 90(2):166-9.
PMID: 2878456
DOI: 10.1007/BF00181234.
Midazolam cue in rats: generalization tests with anxiolytic and other drugs.
Garcha H, Rose I, Stolerman I
Psychopharmacology (Berl). 1985; 87(2):233-7.
PMID: 2864715
DOI: 10.1007/BF00431814.
Hypothermia induced by baclofen, a possible index of GABAB receptor function in mice, is enhanced by antidepressant drugs and ECS.
Gray J, Goodwin G, Heal D, Green A
Br J Pharmacol. 1987; 92(4):863-70.
PMID: 2827829
PMC: 1853729.
DOI: 10.1111/j.1476-5381.1987.tb11392.x.
Loss of muscarinic cholinergic receptors from the temporal cortex of alcohol abusers.
Freund G, Ballinger Jr W
Metab Brain Dis. 1989; 4(2):121-41.
PMID: 2547145
DOI: 10.1007/BF00999390.